Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,396,488
  • Shares Outstanding, K 103,520
  • Annual Sales, $ 482,380 K
  • Annual Income, $ 106,140 K
  • 60-Month Beta 0.48
  • Price/Sales 5.05
  • Price/Cash Flow 24.55
  • Price/Book 4.78
Trade CORT with:

Options Overview Details

View History
  • Implied Volatility 127.31% ( +2.01%)
  • Historical Volatility 38.19%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 127.31% on 04/16/24
  • IV Low 7.91% on 06/05/23
  • Put/Call Vol Ratio 2.14
  • Today's Volume 1,916
  • Volume Avg (30-Day) 1,489
  • Put/Call OI Ratio 1.19
  • Today's Open Interest 64,106
  • Open Int (30-Day) 58,917

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.18
  • Number of Estimates 4
  • High Estimate 0.22
  • Low Estimate 0.10
  • Prior Year 0.14
  • Growth Rate Est. (year over year) +28.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.76 +2.77%
on 04/16/24
26.10 -10.38%
on 04/01/24
+0.16 (+0.69%)
since 03/15/24
3-Month
20.87 +12.08%
on 02/02/24
26.10 -10.38%
on 04/01/24
-1.22 (-4.96%)
since 01/16/24
52-Week
20.87 +12.08%
on 02/02/24
34.28 -31.76%
on 09/14/23
+1.22 (+5.50%)
since 04/14/23

Most Recent Stories

More News
Corcept: Q4 Earnings Snapshot

Corcept: Q4 Earnings Snapshot

CORT : 23.39 (+1.04%)
Corcept Therapeutics, PNM Resources fall; Johnson & Johnson rise, Tuesday, 1/2/2024

Stocks that traded heavily or had substantial price changes on Tuesday: Corcept Therapeutics, PNM Resources fall; Johnson & Johnson rise

BIDU : 96.12 (-0.09%)
PBR-A : N/A (N/A)
PBR : 15.65 (-0.89%)
CORT : 23.39 (+1.04%)
PNM : 35.97 (-0.53%)
JNJ : 144.45 (-2.13%)
ASML : 976.92 (+2.31%)
Corcept: Q3 Earnings Snapshot

Corcept: Q3 Earnings Snapshot

CORT : 23.39 (+1.04%)
Corcept: Q2 Earnings Snapshot

Corcept: Q2 Earnings Snapshot

CORT : 23.39 (+1.04%)
Corcept (CORT) Misses on Q1 Earnings, Revises 2023 Sales Guidance

Corcept (CORT) first-quarter earnings miss estimates, while revenues beat the same. The company gives updates on its pipelines and raises revenue guidance for 2023.

MRK : 125.06 (-0.90%)
CORT : 23.39 (+1.04%)
ALLO : 3.50 (-1.41%)
OCUP : 1.7400 (-1.14%)
Corcept Therapeutics (CORT) Lags Q1 Earnings Estimates

Corcept (CORT) delivered earnings and revenue surprises of -30% and 1.73%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CORT : 23.39 (+1.04%)
TBPH : 9.69 (-2.32%)
Corcept: Q1 Earnings Snapshot

Corcept: Q1 Earnings Snapshot

CORT : 23.39 (+1.04%)
Biotech/Drug Stocks' Q1 Earnings Due May 3: UTHR, PCRX & More

Let us take a look at what's in store for biotech/drug stocks UTHR, PCRX, CORT, AMRN and IONS, which are scheduled to report on May 3.

UTHR : 231.78 (-1.40%)
PCRX : 26.87 (+1.28%)
AMRN : 0.8959 (-2.47%)
CORT : 23.39 (+1.04%)
IONS : 41.54 (-0.02%)
Jazz (JAZZ) Up 0.4% Since Last Earnings Report: Can It Continue?

Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

JAZZ : 108.90 (-1.81%)
CORT : 23.39 (+1.04%)
Why Is Corcept (CORT) Up 9.6% Since Last Earnings Report?

Corcept (CORT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CORT : 23.39 (+1.04%)
TBPH : 9.69 (-2.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone),...

See More

Key Turning Points

3rd Resistance Point 24.66
2nd Resistance Point 24.16
1st Resistance Point 23.77
Last Price 23.39
1st Support Level 22.88
2nd Support Level 22.38
3rd Support Level 21.99

See More

52-Week High 34.28
Fibonacci 61.8% 29.15
Fibonacci 50% 27.57
Fibonacci 38.2% 25.99
Last Price 23.39
52-Week Low 20.87

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar